{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:35:05Z","timestamp":1792960505843,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118550","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:55:40Z","timestamp":1792248940000},"page":"118550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Context-dependent protective and pathogenic functions of YTHDF1 in MASLD and hepatocellular carcinoma: Mechanisms and design of therapeutics"],"prefix":"10.1016","volume":"254","author":[{"given":"Shangyu","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2468-1253(23)00453-3","article-title":"Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice","volume":"9","author":"Brennan","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3350\/cmh.2024.0987","article-title":"Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023","volume":"31","author":"Kim","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2019.07.036","article-title":"ECM1 prevents activation of transforming growth factor \u03b2, hepatic stellate cells, and fibrogenesis in mice","volume":"157","author":"Fan","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7150\/thno.46360","article-title":"Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.bcp.2026.118550_b0040","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0050","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.cell.2026.02.001","article-title":"Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis","volume":"189","author":"Hu","year":"2026","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0055","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.cmet.2024.07.014","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118550_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102378","article-title":"The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis","volume":"54","author":"Sun","year":"2022","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"7397","key":"10.1016\/j.bcp.2026.118550_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118550_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102921","article-title":"YTHDF1 mitigates acute kidney injury via safeguarding m(6)A-methylated mRNAs in stress granules of renal tubules","volume":"67","author":"Yang","year":"2023","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118550_b0085","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0090","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"7860","key":"10.1016\/j.bcp.2026.118550_b0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0140","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41589-020-0524-y","article-title":"m(6)A-binding YTHDF proteins promote stress granule formation","volume":"16","author":"Fu","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/molecules29010140","article-title":"YTHDF1 in tumor cell metabolism: an updated review","volume":"29","author":"Rong","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tips.2023.03.004","article-title":"The structure and function of YTHDF epitranscriptomic m(6)A readers","volume":"44","author":"Sikorski","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0710","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7150\/ijbs.73570","article-title":"N(6)-methyladenosine modification of ANLN enhances hepatocellular carcinoma bone metastasis","volume":"19","author":"Zheng","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0715","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","article-title":"A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23","volume":"164","author":"Saito","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0720","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.7150\/thno.102682","article-title":"Betaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM\/m(6)A\/YTHDF1-mediated enhancement on ATG3 stability","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0725","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2021.09.008","article-title":"Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function","volume":"76","author":"da Silva Lima","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0680","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/jgh.70015","article-title":"m6A modification-mediated regulation of DCAF13 promotes glycolytic metabolism and drives hepatocellular carcinoma progression via interaction with G6PD","volume":"40","author":"Liu","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"26","key":"10.1016\/j.bcp.2026.118550_b0730","article-title":"SNORA74A Drives Self-Renewal of Liver Cancer Stem Cells and Hepatocarcinogenesis Through Activation of Notch3 Signaling","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bcp.2026.118550_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106608","article-title":"ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation","volume":"187","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0735","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41418-024-01343-0","article-title":"GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver","volume":"31","author":"Zhu","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0290","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00018-024-05420-y","article-title":"Epitranscriptomic regulation of lipid oxidation and liver fibrosis via ENPP1 mRNA m(6)A modification","volume":"81","author":"Sun","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118550_b0740","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2024.04.207","article-title":"TET3 boosts hepatocyte autophagy and impairs non-alcoholic fatty liver disease by increasing ENPP1 promoter hypomethylation","volume":"218","author":"Sun","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0360","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0305","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41401-023-01145-z","article-title":"LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"22","key":"10.1016\/j.bcp.2026.118550_b0745","article-title":"METTL14-Induced M(6)A methylation increases G6pc biosynthesis, hepatic glucose production and metabolic disorders in obesity","volume":"12","author":"Zheng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"22","key":"10.1016\/j.bcp.2026.118550_b0750","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0755","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2022.10.015","article-title":"GLIS2 prevents hepatic fibrosis by competitively binding HDAC3 to inhibit hepatic stellate cell activation","volume":"15","author":"Zhang","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0165","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2599543","article-title":"Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m(6)A modification","volume":"17","author":"Chen","year":"2025","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0210","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s12276-025-01445-w","article-title":"Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD(+)-dependent sirtuin-3 activation","volume":"57","author":"Wang","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0760","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41420-025-02462-4","article-title":"Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1","volume":"11","author":"Quan","year":"2025","journal-title":"Cell Death Discov"},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0765","doi-asserted-by":"crossref","first-page":"e0771","DOI":"10.1097\/HC9.0000000000000771","article-title":"Alcohol-induced KDM5B activation in hepatocytes drives pathogenic cell-cell communication, leading to loss of liver function","volume":"9","author":"Nataraj","year":"2025","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0770","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","article-title":"N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0775","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12072-025-10978-1","article-title":"Positive feedback between histone H4K16 lactylation and glycolysis promotes MAFLD progression","volume":"20","author":"Jiao","year":"2025","journal-title":"Hep. Intl."},{"key":"10.1016\/j.bcp.2026.118550_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110673","article-title":"TUG1 protects against ferroptosis of hepatic stellate cells by upregulating PDK4-mediated glycolysis","volume":"383","author":"Zhang","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0220","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.1038\/s41467-025-65982-8","article-title":"Diet-induced RKIP downregulation disrupts PC\/PE-ER homeostasis to drive MASLD","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0785","doi-asserted-by":"crossref","first-page":"G526","DOI":"10.1152\/ajpgi.00243.2015","article-title":"Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice","volume":"310","author":"van der Veen","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0265","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0255","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0790","doi-asserted-by":"crossref","first-page":"985","DOI":"10.33549\/physiolres.935289","article-title":"LDHA- mediated histone lactylation promotes the nonalcoholic fatty liver disease progression through targeting the METTL3\/ YTHDF1\/SCD1 m6A Axis","volume":"73","author":"Meng","year":"2024","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcp.2026.118550_b0795","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2025.08.035","article-title":"FATP5 deficiency alleviates MASH via remodeling hepatic lipid composition to suppress ferroptosis","volume":"240","author":"Liu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0800","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.7150\/ijbs.86658","article-title":"The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma","volume":"20","author":"Zeng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0805","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41388-022-02551-z","article-title":"Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13157","article-title":"YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation","volume":"55","author":"Li","year":"2022","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0810","doi-asserted-by":"crossref","first-page":"bqab007","DOI":"10.1210\/endocr\/bqab007","article-title":"Hepatic Ago2 regulates PPAR\u03b1 for oxidative metabolism linked to glycemic control in obesity and post bariatric surgery","volume":"162","author":"Bhattacharjee","year":"2021","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0675","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12272-023-01480-z","article-title":"The PIN1-YTHDF1 axis promotes breast tumorigenesis via the m(6)A-dependent stabilization of AURKA mRNA","volume":"47","author":"Shrestha","year":"2024","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0815","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jhep.2014.02.004","article-title":"Pin1 induction in the fibrotic liver and its roles in TGF-\u03b21 expression and Smad2\/3 phosphorylation","volume":"60","author":"Yang","year":"2014","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0820","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.3390\/ijms25115822","article-title":"Pin1 exacerbates non-alcoholic fatty liver disease by enhancing its activity through binding to ACC1","volume":"25","author":"Jin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.bcp.2026.118550_b0825","article-title":"RBMS1 coordinates with the m(6)A Reader YTHDF1 to promote NSCLC metastasis through stimulating S100P translation","volume":"11","author":"Sun","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bcp.2026.118550_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.158399","article-title":"Fupenzic acid ameliorates radiation-induced liver fibrosis by regulating RBMS1 to inhibit the cGAS-STING pathway and restore mitochondrial function","volume":"159","author":"Guo","year":"2026","journal-title":"Phytomedicine"},{"issue":"17","key":"10.1016\/j.bcp.2026.118550_b0835","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1158\/0008-5472.CAN-23-2081","article-title":"RUVBL1\/2 blockade targets YTHDF1 activity to suppress m6a-dependent oncogenic translation and colorectal tumorigenesis","volume":"84","author":"Chen","year":"2024","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0840","article-title":"Targeting RuvBL1 disrupts mitochondrial metabolism and structure in hepatocellular carcinoma","volume":"8","author":"Mello","year":"2026","journal-title":"JHEP Rep"},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0110","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/cr.2014.153","article-title":"Structure of the YTH domain of human YTHDF2 in complex with an m(6)A mononucleotide reveals an aromatic cage for m(6)A recognition","volume":"24","author":"Li","year":"2014","journal-title":"Cell Res."},{"issue":"38","key":"10.1016\/j.bcp.2026.118550_b0115","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1073\/pnas.1412742111","article-title":"Molecular basis for the recognition of methylated adenines in RNA by the eukaryotic YTH domain","volume":"111","author":"Luo","year":"2014","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nchembio.1654","article-title":"Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain","volume":"10","author":"Xu","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0130","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A Unified Model for the Function of YTHDF Proteins in Regulating m(6)A-Modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bcp.2026.118550_b0135","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1016\/j.molcel.2023.10.028","article-title":"FMRP phosphorylation modulates neuronal translation through YTHDF1","volume":"83","author":"Zou","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118550_b0145","doi-asserted-by":"crossref","unstructured":"Wang, J., et al., Binding to m(6)A RNA promotes YTHDF2-mediated phase separation, in Protein Cell. 2020: Germany. p. 304\u2013307.","DOI":"10.1007\/s13238-019-00660-2"},{"issue":"41","key":"10.1016\/j.bcp.2026.118550_b0150","doi-asserted-by":"crossref","first-page":"24902","DOI":"10.1074\/jbc.M115.680389","article-title":"Structural basis for the discriminative recognition of N6-methyladenosine RNA by the human YT521-B Homology domain family of proteins","volume":"290","author":"Xu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0160","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s12276-026-01686-3","article-title":"Noncanonical function of epigenetic reader YTHDF1 inhibits MASLD progression by maintaining peroxisomes and mitochondrial homeostasis","volume":"58","author":"Mu","year":"2026","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41435-025-00367-x","article-title":"YTHDF1 mediates KLF2\/VSIG4 axis to regulate Kupffer cell polarization to alleviate sepsis-induced liver injury","volume":"27","author":"Sun","year":"2026","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0175","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s13577-022-00769-3","article-title":"METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma","volume":"35","author":"Hu","year":"2022","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41467-025-67707-3","article-title":"Activation of the RSAD2-YTHDF1 axis in smooth muscle causes inflammatory bowel disease via intercellular mitochondrial transfer","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.bcp.2026.118550_b0185","doi-asserted-by":"crossref","first-page":"15536","DOI":"10.3390\/ijms242115536","article-title":"Changes in plasma pyruvate and TCA cycle metabolites upon increased hepatic fatty acid oxidation and ketogenesis in male wistar rats","volume":"24","author":"Dankel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.bcp.2026.118550_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2879","article-title":"\u03b1-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling","volume":"8","author":"Yuan","year":"2022","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41419-024-07151-1","article-title":"Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression","volume":"15","author":"Zhao","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0200","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1096\/fj.201701429R","article-title":"The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism","volume":"32","author":"Rajasekaran","year":"2018","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0205","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/hep.26060","article-title":"Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function","volume":"57","author":"Martin","year":"2013","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118550_b0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000452524","article-title":"Raf kinase inhibitory protein down-expression exacerbates hepatic fibrosis in vivo and in vitro","volume":"40","author":"Huang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"16","key":"10.1016\/j.bcp.2026.118550_b0225","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.3390\/ijms23169296","article-title":"Hepatic PEMT expression decreases with increasing NAFLD severity","volume":"23","author":"Piras","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0230","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70539","article-title":"MTARC1 inactivation remodels lipid droplets to protect against metabolic fatty liver disease","volume":"46","author":"Tie","year":"2026","journal-title":"Liver Int."},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0235","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1096\/fj.201900679R","article-title":"Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.bcp.2026.118550_b0245","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"PNAS"},{"issue":"16","key":"10.1016\/j.bcp.2026.118550_b0250","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0260","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/s41467-025-61965-x","article-title":"Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis","volume":"16","author":"Lan","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0270","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1038\/s41467-024-53733-0","article-title":"PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity","volume":"15","author":"Gilglioni","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0275","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1007\/s00464-024-11177-z","article-title":"Association between Helicobacter pylori infection, MASLD, and liver fibrosis in patients with severe obesity: a single-center experience","volume":"38","author":"Gulati","year":"2024","journal-title":"Surg. Endosc."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101541","article-title":"Helicobacter pylori cagA\/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease","volume":"29","author":"Maiorana","year":"2024","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115350","article-title":"Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0315","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41418-023-01130-3","article-title":"DNA 5mC and RNA m(6)A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression","volume":"30","author":"Feng","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0685","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1038\/s41467-025-59218-y","article-title":"Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation","volume":"16","author":"Al Sayegh","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118550_b0300","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cmet.2021.06.005","article-title":"Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication","volume":"33","author":"Loft","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40104-026-01380-4","article-title":"METTL3 inhibition attenuates AFB(1)-induced hepatic fibrosis by suppressing m(6)A-mediated hepatic stellate cell activation","volume":"17","author":"Zhao","year":"2026","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"16","key":"10.1016\/j.bcp.2026.118550_b0845","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.7150\/ijbs.75063","article-title":"ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0850","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/s41467-026-69731-3","article-title":"Arginase 1 promotes hepatic lipogenesis by regulating ERK2\/PPAR\u03b3 signaling in a non-canonical manner","volume":"17","author":"Shao","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0855","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/HEP.0000000000000985","article-title":"Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1\u03b1","volume":"82","author":"Hai","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102197","article-title":"Multilayer and MATR3-dependent regulation of mRNAs maintains pluripotency in human induced pluripotent stem cells","volume":"24","author":"Pollini","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2026.118550_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217231","article-title":"MATR3 promotes liver cancer progression by suppressing DHX58-mediated type I interferon response","volume":"604","author":"Xiao","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0870","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1186\/s12951-025-03861-6","article-title":"YTHDF1 transcriptionally activated by TCF4 suppresses osteoblast ferroptosis in titanium nanoparticle-induced osteolysis by accelerating GPX4 and SLC7A11 translation","volume":"23","author":"Zhong","year":"2025","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0875","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","article-title":"Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex","volume":"79","author":"Wang","year":"2024","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2026.118550_b0880","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/acs.biochem.4c00491","article-title":"TCF7l2 regulates fatty acid chain elongase HACD3 during lipid-induced stress","volume":"64","author":"Mondal","year":"2025","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0885","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s12035-023-03735-8","article-title":"Usf2 deficiency promotes autophagy to alleviate cerebral ischemia-reperfusion injury through suppressing YTHDF1-m6A-mediated Cdc25A translation","volume":"61","author":"Liu","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0890","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41419-022-05363-x","article-title":"USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt\/mTOR signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0320","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1080\/02699052.2023.2237881","article-title":"Propofol suppresses OGD\/R-induced ferroptosis in neurons by inhibiting the HIF-1\u03b1\/YTHDF1\/BECN1 axis","volume":"37","author":"Ma","year":"2023","journal-title":"Brain Inj."},{"issue":"5","key":"10.1016\/j.bcp.2026.118550_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.11.009","article-title":"Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1\/SLC7A11 axis","volume":"14","author":"Lin","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bcp.2026.118550_b0330","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.freeradbiomed.2025.02.031","article-title":"Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein","volume":"231","author":"Li","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118550_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102151","article-title":"N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells","volume":"47","author":"Shen","year":"2021","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0340","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2024.08.029","article-title":"Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression","volume":"82","author":"Xu","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.118550_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218353","article-title":"YTHDF1-mediated RNA m1A methylation promotes malignant progression of hepatocellular carcinoma via regulating LRP5\/Wnt-\u03b2-catenin axis","volume":"645","author":"Gu","year":"2026","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0355","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/0008-5472.CAN-23-1916","article-title":"N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0370","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/acsptsci.2c00008","article-title":"Small-molecule ebselen binds to YTHDF proteins interfering with the recognition of N (6)-methyladenosine-modified RNAs","volume":"5","author":"Micaelli","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41392-026-02695-4","article-title":"Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis","volume":"11","author":"Wang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10098","key":"10.1016\/j.bcp.2026.118550_b0380","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(17)31791-9","article-title":"Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"390","author":"Kil","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0385","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1007\/s00213-020-05654-1","article-title":"A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania","volume":"237","author":"Sharpley","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2026.118550_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156671","article-title":"Ebselen improves lipid metabolism by activating PI3K\/Akt and inhibiting TLR4\/JNK signaling pathway to alleviate nonalcoholic fatty liver","volume":"181","author":"Pan","year":"2024","journal-title":"Cytokine"},{"issue":"68","key":"10.1016\/j.bcp.2026.118550_b0395","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1039\/C8CC04258F","article-title":"Target discovery of ebselen with a biotinylated probe","volume":"54","author":"Chen","year":"2018","journal-title":"Chem. Commun. (Camb)"},{"issue":"41","key":"10.1016\/j.bcp.2026.118550_b0400","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202509316","article-title":"Identification of a selective YTHDF1 inhibitor targeting the m(6)A recognition domain for breast cancer","volume":"64","author":"Wu","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0690","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0695","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"8016","key":"10.1016\/j.bcp.2026.118550_b0700","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2026.118550_b0475","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.21037\/tcr-2025-713","article-title":"The role of YTHDF1 in the diagnosis and prognosis of lung adenocarcinoma and its inhibitor LY-411575 in the targeted intervention of lung adenocarcinoma growth","volume":"14","author":"Wang","year":"2025","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0705","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T","article-title":"High throughput docking for library design and library prioritization","volume":"43","author":"Diller","year":"2001","journal-title":"Proteins"},{"issue":"19","key":"10.1016\/j.bcp.2026.118550_b0895","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.3390\/ijms26199416","article-title":"Ebselen suppresses breast cancer tumorigenesis by inhibiting YTHDF1-mediated c-fos expression","volume":"26","author":"Vasukutty","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118550_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106669","article-title":"Segetalin B promotes bone formation in ovariectomized mice by activating PLD1\/SIRT1 signaling to inhibit \u03b3-secretase-mediated Notch1 overactivation","volume":"247","author":"Du","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0610","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3350\/cmh.2014.20.4.347","article-title":"Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B","volume":"20","author":"Cho","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"issue":"23","key":"10.1016\/j.bcp.2026.118550_b0405","article-title":"MSL1 promotes liver regeneration by driving phase separation of STAT3 and histone H4 and enhancing their acetylation","volume":"10","author":"He","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0410","first-page":"36","article-title":"Glucocorticoids trigger muscle-liver crosstalk to attenuate acute liver injury and promote liver regeneration via the FGF6-FGFBP1 axis","volume":"12","author":"Xu","year":"2025","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bcp.2026.118550_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217508","article-title":"Phase separation of EEF1E1 promotes tumor stemness via PTEN\/AKT-mediated DNA repair in hepatocellular carcinoma","volume":"613","author":"Pu","year":"2025","journal-title":"Cancer Lett."},{"issue":"7765","key":"10.1016\/j.bcp.2026.118550_b0420","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","article-title":"m(6)A enhances the phase separation potential of mRNA","volume":"571","author":"Ries","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0425","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2020.03.046","article-title":"G3BP1 is a tunable switch that triggers phase separation to assemble stress granules","volume":"181","author":"Yang","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0430","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1038\/s41467-025-63022-z","article-title":"Dysregulation of GTPase-activating protein-binding protein1 in the pathogenesis of metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Ouyang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118550_b0435","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molmet.2019.01.002","article-title":"The translational regulator FMRP controls lipid and glucose metabolism in mice and humans","volume":"21","author":"Leboucher","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2026.118550_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109021","article-title":"Salvianolic acid C improves cerebral ischemia reperfusion injury through suppressing microglial cell M1 polarization and promoting cerebral angiogenesis","volume":"110","author":"Shen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118550_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116400","article-title":"Salvianolic acid C attenuates liver fibrosis and inhibites hepatic stellate cell activation by targeting FAP\/T\u03b2RI\/SMAD axis","volume":"175","author":"Sun","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0450","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/bmc.3558","article-title":"Determination of salvianolic acid C in rat plasma using liquid chromatography-mass spectrometry and its application to pharmacokinetic study","volume":"30","author":"Song","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0455","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.3390\/ijms23074033","article-title":"The potential role of phenolic acids from salvia miltiorrhiza and cynara scolymus and their derivatives as JAK inhibitors: an in silico study","volume":"23","author":"Liao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0460","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41392-022-01097-6","article-title":"Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response","volume":"7","author":"Zeng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118550_b0465","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5114\/ceji.2024.145013","article-title":"Interleukin 17A promotes glycolysis to activate human hepatic stellate cells by mediating the TRAF2\/TRAF5\/HuR\/PFKFB3 axis","volume":"49","author":"Jiang","year":"2024","journal-title":"Cent Eur J Immunol"},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0470","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/s41401-024-01389-3","article-title":"SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0480","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.104.073965","article-title":"Lack of specific amyloid-beta(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures","volume":"312","author":"Lanz","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0485","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1021\/acsnano.0c01007","article-title":"Targeted delivery of notch inhibitor attenuates obesity-induced glucose intolerance and liver fibrosis","volume":"14","author":"Richter","year":"2020","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.bcp.2026.118550_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166800","article-title":"Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production","volume":"1869","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0495","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/s41366-018-0027-z","article-title":"mRNA m(6)A plays opposite role in regulating UCP2 and PNPLA2 protein expression in adipocytes","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Obes. (Lond)"},{"issue":"7969","key":"10.1016\/j.bcp.2026.118550_b0500","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0505","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.cell.2024.04.005","article-title":"Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"issue":"8052","key":"10.1016\/j.bcp.2026.118550_b0510","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41586-024-08421-w","article-title":"Targeting FOXM1 condensates reduces breast tumour growth and metastasis","volume":"638","author":"Xie","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41557-024-01663-1","article-title":"Spatiotemporal protein interactome profiling through condensation-enhanced photocrosslinking","volume":"17","author":"Li","year":"2025","journal-title":"Nat. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0520","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.32332","article-title":"Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase","volume":"76","author":"Fang","year":"2022","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0525","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.immuni.2024.08.016","article-title":"Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Guo","year":"2024","journal-title":"Immunity"},{"issue":"599","key":"10.1016\/j.bcp.2026.118550_b0530","doi-asserted-by":"crossref","first-page":"eabe1692","DOI":"10.1126\/scitranslmed.abe1692","article-title":"Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis","volume":"13","author":"Yu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0535","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1021\/acs.molpharmaceut.3c00370","article-title":"In Vivo imaging of [60]fullerene-based molecular spherical nucleic acids by positron emission tomography","volume":"20","author":"\u00c4\u00e4rel\u00e4","year":"2023","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0540","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/antiox10060911","article-title":"Effects of C60 fullerene on thioacetamide-induced rat liver toxicity and gut microbiome changes","volume":"10","author":"\u0110ura\u0161evi\u0107","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0545","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/gutjnl-2025-336268","article-title":"Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD","volume":"75","author":"Zou","year":"2026","journal-title":"Gut"},{"issue":"22","key":"10.1016\/j.bcp.2026.118550_b0550","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501360","article-title":"Pyrrolidinium fullerenes as YTHDF1 inhibitors for targeted tumor therapy","volume":"14","author":"Wang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.bcp.2026.118550_b0600","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202513577","article-title":"A biomimetic MOF-based \u201cdual-stage cumulative activation\u201d autophagic degradation system to counter tumor recurrence following incomplete radiofrequency ablation of hepatocellular carcinoma","volume":"38","author":"Wang","year":"2026","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0555","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acsnano.9b10015","article-title":"Protein binding affinity of polymeric nanoparticles as a direct indicator of their pharmacokinetics","volume":"14","author":"Cao","year":"2020","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bcp.2026.118550_b0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/17435390.2020.1863498","article-title":"Acute exposure to C60 fullerene damages pulmonary mitochondrial function and mechanics","volume":"15","author":"Caldeira","year":"2021","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.bcp.2026.118550_b0565","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2147\/IJN.S403058","article-title":"Identification and biological evaluation of a water-soluble fullerene nanomaterial as BTK kinase inhibitor","volume":"18","author":"Malarz","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.bcp.2026.118550_b0570","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.3390\/ijms23105714","article-title":"Water-soluble, alanine-modified fullerene C(60) promotes the proliferation and neuronal differentiation of neural stem cells","volume":"23","author":"Ren","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0575","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10867-023-09631-5","article-title":"Electrostatic effects on water-soluble fullerene derivatives interaction with cytochrome c and cytochrome c oxidase","volume":"49","author":"Poletaeva","year":"2023","journal-title":"J. Biol. Phys."},{"issue":"15","key":"10.1016\/j.bcp.2026.118550_b0580","article-title":"A DNA\/DMXAA\/metal-organic framework activator of innate immunity for boosting anticancer immunity","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.bcp.2026.118550_b0585","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1021\/acsnano.2c12075","article-title":"Confined cascade metabolic reprogramming nanoreactor for targeted alcohol detoxification and alcoholic liver injury management","volume":"17","author":"Geng","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0590","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00775-006-0169-7","article-title":"Gallium uptake by transferrin and interaction with receptor 1","volume":"12","author":"Chikh","year":"2007","journal-title":"J. Biol. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118550_b0595","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjms.2017.08.012","article-title":"Iron enhances hepatic fibrogenesis and activates transforming growth factor-\u03b2 signaling in murine hepatic stellate cells","volume":"355","author":"Mehta","year":"2018","journal-title":"Am. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0605","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1080\/15548627.2023.2234797","article-title":"Tethering ATG16L1 or LC3 induces targeted autophagic degradation of protein aggregates and mitochondria","volume":"19","author":"Mei","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2026.118550_b0615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2024.05.008","article-title":"YTHDF1 is pivotal for maintenance of cardiac homeostasis","volume":"193","author":"Golubeva","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0620","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.molcel.2025.05.003","article-title":"YTHDF1 differentiates the contributing roles of mTORC1 in aging","volume":"85","author":"Xu","year":"2025","journal-title":"Mol. Cell"},{"issue":"26","key":"10.1016\/j.bcp.2026.118550_b0625","doi-asserted-by":"crossref","first-page":"23876","DOI":"10.1021\/acsnano.5c05144","article-title":"Oral administration of a tetrahedral framework DNA-based nanoshot attenuates liver fibrosis via targeting galectin-3","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2026.118550_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123576","article-title":"Oral delivery of chitosan-bilirubin nanoparticles alleviates hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"325","author":"Rahman","year":"2026","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.bcp.2026.118550_b0635","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid-bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0640","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202228","article-title":"CD44-targeting drug delivery system of exosomes loading forsythiaside A combats liver fibrosis via regulating NLRP3-mediated pyroptosis","volume":"12","author":"Gong","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"49","key":"10.1016\/j.bcp.2026.118550_b0645","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1021\/acs.nanolett.4c04820","article-title":"Hepatic stellate cell membrane-camouflaged nanoparticles for targeted delivery of an antifibrotic agent to hepatic stellate cells with enhanced antifibrosis efficacy","volume":"24","author":"Cheng","year":"2024","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.bcp.2026.118550_b0650","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1021\/acsnano.6c00741","article-title":"Cellular adaptive component-mediated targeting of chylomicron-mimic nanoemulsion to hepatic stellate cells for liver fibrosis","volume":"20","author":"Hu","year":"2026","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bcp.2026.118550_b0655","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41467-025-57382-9","article-title":"Impact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes","volume":"16","author":"Ferriero","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2026.118550_b0660","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3390\/pharmaceutics14112396","article-title":"Microbubble-nanoparticle complexes for ultrasound-enhanced cargo delivery","volume":"14","author":"Chapla","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118550_b0665","article-title":"Human clinical trial using diagnostic ultrasound and microbubbles to enhance neoadjuvant chemotherapy in HER2- negative breast cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118550_b0670","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2023.05.002","article-title":"Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosis","volume":"358","author":"Chen","year":"2023","journal-title":"J. Control. Release"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:18:54Z","timestamp":1792959534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":180,"alternative-id":["S0006295226008932"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118550","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context-dependent protective and pathogenic functions of YTHDF1 in MASLD and hepatocellular carcinoma: Mechanisms and design of therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118550"}}